Zarontin (Ethosuximide) 250 mg, 56 capsules: profile, composition and research
Reference page for Zarontin (Ethosuximide) 250 mg, 56 capsules. Active substance: Этосуксимид / Ethosuximide.
- What it is: ethosuximide, an anticonvulsant from the succinimide group.
- Presentation: 250 mg capsules, 56 capsules per pack.
- Status: prescription-only medicine.
- Research: comparative and review work in absence epilepsy, links below.
- Where to buy: APV Pharmacy (price and availability there).
Key facts
| Active substance | Ethosuximide |
|---|---|
| Form | Capsules |
| Strength | 250 mg per capsule |
| Pack size | 56 capsules |
| Category | Prescription medicine |
| Article (SKU) |
What ethosuximide is
Ethosuximide belongs to the succinimides, a narrow group of anticonvulsants. The molecule has been known since the 1960s and remains one of the few substances that target absence seizures, called petit mal in older literature.
An absence seizure looks like a brief lapse of consciousness without falling: the person freezes for a few seconds, then resumes what they were doing and often has no memory of the gap. Such seizures frequently start in childhood, which is why the medicine is associated mainly with paediatric practice.
It is supplied as 250 mg capsules. A pack of 56 capsules fits a course lasting months: treatment of absence epilepsy is almost always long-term.
How ethosuximide works
The target
The medicine acts on T-type calcium channels in thalamic cells. These channels sustain the rhythmic, synchronous firing of neurons that generates an absence seizure.
What changes
Once the channels are blocked, calcium entry into the cell falls and the abnormal rhythm of the thalamocortical loop breaks up. Seizure frequency and duration drop, although full control is not achieved in every patient.
Why the spectrum is narrow
Focal and tonic-clonic seizures respond to ethosuximide much less. That is why it is given for a specific epilepsy syndrome rather than as a broad-spectrum drug.
Approved uses
The manufacturer's prescribing information lists absence seizures in adults and children, including use as part of combined treatment of other epilepsy syndromes when a treating physician decides so.
Succinimides are chosen according to seizure type, age and examination findings. Selecting the therapy, the number of intakes and the length of the course remain a physician's task, while a reference page is only general background.
Stopping anticonvulsant treatment abruptly can trigger more frequent seizures. Any change to the regimen is discussed with a doctor in advance.
What to keep in mind
The most common reports are drowsiness, headache, nausea, poor appetite and hiccups. Some of these ease as the body adjusts, yet a doctor should still be told about them.
Rarely, blood counts may change and allergic reactions may occur, including severe skin reactions. Monitoring tests and specialist follow-up are therefore part of standard care.
Pregnancy, breastfeeding, liver or kidney disease, and taking other medicines at the same time all need a separate discussion with a doctor.
Published research
Primary sources, verified against PubMed:
- Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy., PubMed 20200383 (The New England journal of medicine, 2010).
- Antiseizure medications for idiopathic generalized epilepsies: a systematic review and network meta-analysis., PubMed 37378757 (Journal of neurology, 2023).
- Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society., PubMed 29898971 (Neurology, 2018).
Listed for reference. Publication of a study is not a claim about this particular product.
Precautions
- This is a prescription medicine. Prescribing, dose selection and monitoring belong to a physician.
- Stopping it abruptly may make seizures more frequent. Changes to treatment are agreed with a doctor.
- Drowsiness, headache, nausea, poor appetite and hiccups may occur. Persistent or unusual symptoms should be reported to a doctor.
- Blood monitoring is ordered by a physician, particularly during long-term use.
- A skin rash or other signs of allergy require a doctor without delay.
- Use during pregnancy or breastfeeding is discussed with a doctor individually.
- Tell your doctor about every other medicine you take: interactions are possible.
Frequently asked
Is Zarontin a prescription medicine?
Yes. It is a prescription anticonvulsant and is not intended for use on one's own.
Why does this page not give a dosing schedule?
The regimen depends on the epilepsy syndrome, age and the patient's condition. That is a treating physician's decision, not a reference page's.
Which seizures is ethosuximide used for?
It is approved for absence seizures. In other forms of epilepsy the choice belongs to a doctor, including within combination therapy.
Where does the order ship from?
Shipping and customs handling are described on the APV Pharmacy delivery page.